Yüklüyor......
Treatment of metastatic colorectal cancer: focus on panitumumab
Targeted agents are an important therapeutic option in the treatment of metastatic colorectal cancer (mCRC). Panitumumab is a recombinant, fully humanized, immunoglobulin G2 monoclonal antibody that targets the epidermal growth factor receptor (EGFR) with efficacy in mCRC as monotherapy and in combi...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484697/ https://ncbi.nlm.nih.gov/pubmed/26150735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S71821 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|